Country - United States
Summary - Treating Hereditary Rare Diseases With In Vivo Precision Genetic Medicines (Thrive)
Deadline - Dec 19, 2025
MT reference number - 118928703
Product classification - Various medicinal products
Address - United States
Contact details - 565656565
Tender notice no. - 76454545
MT Ref Id - 118928703
Document Type - Tender Notices
Description - Description: The Advanced Research Projects Agency for Health (ARPA-H) Treating Hereditary Rare diseases with In Vivo precision genetic mEdicines (THRIVE) program envisions a future where patients can opt for one-time therapeutic interventions design ed to slow, reverse, or cure disease, harnessing revolutionary technologies and a rapidly evolving understanding of the genetic underpinnings of the biological processes that lead to disease. Interested parties are invited to review the attached THRIVE Innovative Solutions Opening (ISO) ARPA-H -SOL-25-122. For detailed information regarding Proposers' Day review Special Notice (SN) ARPA-H-SN-25-131. Solution summaries are due October 31, 2025, 11
Mt Ref Id - 118928703
Deadline - Dec 19, 2025
Similar Tenders :
Healthcare and Medicine